UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported) |
July 25, 2002 |
||
Advanced Biotherapy, Inc.
Delaware |
0-26323
|
95-0402415 |
||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 6355 Topanga Canyon Boulevard, Suite 510 | 91367 | ||||
|
|
|||||
| Woodland Hills, California | (Zip Code) | ||||
| (Address of principal executive offices) |
| Registrant’s telephone number, including area code | (818) 883-6716 | |
|
|
| Item 5. OTHER EVENTS. | ||||||||
| Item 7. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| Signatures | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. OTHER EVENTS.
The registrant published a press release on July 25, 2002, which reported that Dr. Hillel Panitch, Professor of Neurology and Director of the Multiple Sclerosis Center at Fletcher Allen Health Center, University of Vermont College of Medicine, has joined Advanced Biotherapy, Inc.’s Multiple Sclerosis Scientific Advisory Board.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
Designation 99.1 |
Description of Exhibit Press Release, dated July 25, 2002 |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ADVANCED BIOTHERAPY, INC. (Registrant) |
|||||||
Date:July 25, 2002 |
By:
|
/s/ Edmond Buccellato |
|||||
Edmond Buccellato, President and CEO |
|||||||
INDEX TO EXHIBITS
Exhibit |
Description |
|
99.1 |
Text of Press Release, dated July 25, 2002 |